Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian equity markets close on a high note
Tue, 5 Mar Closing

Indices in the Indian equity market continued their journey in the positive zone and closed the day on a high note. The Sensex today closed higher by around 265 points (up 1.4%) while the NSE-Nifty saw an increase of around 86 points. BSE Mid Cap and BSE Small Cap indices fared well too gaining 1.7% and 1.1% respectively. Nearly five stocks gained for every one that closed in the red on the Sensex today.

Barring Indonesia, the other major Asian indices also closed in the green today. Europe is trading in the positive zone as well. The rupee was placed at Rs 54.82 to the dollar at the time of writing.

PSU banking stocks closed the day on a high note with Union Bank, UCO Bank and Dena Bank leading the pack of gainers. The country's largest bank State Bank of India (SBI) has given a recruitment target of 1,200 people this year. The bank plans to hire more people in order to improve its services. The bank has been on a recruitment drive for quite some time. As per Economic times, it hired nearly 40,000 people in the last five years. The recruitment activity has been stepped up as nearly 40% of the bank's existing staff is set to leave over the next 3 to 4 years. This is due to super annuation. At present, the bank's total head count stands at 220,000. It has a customer base of around 230 m currently. As per the bank's Managing Director, SBI aims to expand its customer base to 250 m by the end of this year. The stock closed higher by about 1.5% today.

Pharma stocks have closed the day in the green with Wockhardt Ltd, Natco Pharma and Aurobindo Pharma leading the gains. However, the stocks of Glenmark Pharma and Panacea Biotech witnessed selling pressure. Dr. Reddy's Laboratories (DRL) has launched a generic version Zoledronic Acid injection. This is following the ANDA approval received from the US FDA. The injection would be launched in the American markets. The injection is a generic version of Novartis Oncology's Zometa injection in the same strength. The drug is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It is also used for treating osteoporosis. DRL has stated that the injection would be available in a single use vial of concentrate. The stock closed the day higher by 1.5%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian equity markets close on a high note". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.